A drug called Aviptadil shows promise in defeating the syndrome that accounts for around half of all corona-related deaths.
An Israeli company called Neurorx is currently testing a drug called Aviptadil, which could treat acute respiratory distress syndrome (ARDS), the condition responsible for around 50% of all coronavirus fatalities.
On Sunday, the U.S. Food and Drug Administration gave approval to NeuroRx for phase two trials of Aviptadil.
While this is not a complete drug approval for Covid-19-related use of the drug, it does mean the treatment is one step closer to getting the greenlight for patient use.
(adsbygoogle = window.adsbygoogle || []).push({});
(adsbygoogle = window.adsbygoogle || []).push({});
(adsbygoogle = window.adsbygoogle || []).push({});
(adsbygoogle = window.adsbygoogle || []).push({});
URGENT: Help Israelis Fight Coronavirus!
Donate to the Israel Coronavirus Relief Fund. The deadly virus is surging in Israel. While all Israelis are affected, the poor, elderly and seriously ill are highly at risk.
Israeli soldiers, security officers and medical care providers are in danger. At this time, Coronavirus poses a greater threat to Israel than acts of terror.
Israelis need your help. Food and medical supplies can be scarce. The country is in near total lockdown. People are in panic. Funds will be distributed where needed most. Help Israel today!
Source: United with Israel
